The Trump administration confirmed it is reevaluating a $590 million human bird flu vaccine contract awarded to Moderna in ...

Moderna shares fell 3% Thursday afternoon, after reports that federal health officials are re-evaluating the company’s $590 million contract to help develop a bird-flu vaccine. Moderna was awarded the ...

The Trump administration has canceled an upcoming meeting of the Food and Drug Administration’s vaccine advisory committee, a ...

The Trump administration is reviewing a contract extended to Moderna in the final days of the Biden administration.

Moderna Inc.'s stock tumbled 4% Thursday, after a report that health officials are reviewing a contract the company won from the Biden administration to support its efforts to develop a bird-flu ...

Moderna (NASDAQ: MRNA) became a hot investment during the pandemic as its COVID vaccine made investors bullish on its future.

US health officials are reevaluating a $590 million contract for bird flu shots that the Biden administration awarded to ...

A $590 million contract awarded to Moderna by the U.S. government to aid in vaccine development for bird flu is being ...

Moderna is one of the pharmaceutical companies best known for developing the messenger RNA vaccine against Covid-19.

The back-to-back high-level disruptions in vaccine policy under Robert F. Kennedy Jr comes as the U.S. records its first ...

U.S. health officials are reevaluating a $590M bird flu vaccine contract that was awarded to Moderna ( NASDAQ: MRNA) by the ...

American pharmaceutical company Moderna (MRNA) is reportedly under scrutiny by U.S. President Donald Trump’s team, which is ...